Sentiss Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SENTISS, and what generic and branded alternatives to SENTISS drugs are available?
SENTISS has twelve approved drugs.
Drugs and US Patents for Sentiss
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sentiss | ERYTHROMYCIN | erythromycin | OINTMENT;OPHTHALMIC | 064030-001 | Jul 18, 1996 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sentiss | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | brimonidine tartrate; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 091086-001 | Oct 31, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sentiss | BROMFENAC SODIUM | bromfenac sodium | SOLUTION/DROPS;OPHTHALMIC | 203395-001 | Jan 22, 2014 | AT2 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sentiss | LOTEPREDNOL ETABONATE | loteprednol etabonate | GEL;OPHTHALMIC | 212080-001 | Feb 10, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.